Home / Publications / Pain Research Forum / Papers of the Week / Chronic Prostatitis/Chronic Pelvic Pain Syndrome patients show Th1 and Th17 self-reactive immune responses specific to prostate and seminal antigens and decreased semen quality.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome patients show Th1 and Th17 self-reactive immune responses specific to prostate and seminal antigens and decreased semen quality.
To assess the presence of self-reactive immune responses to seminal and prostate antigens (PAg), biomarkers of inflammation of the male genital tract and semen quality parameters in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
